Cui Rutao (Senior Scientist) is a Qiushi Chair Professor at Zhejiang University. From 2015 to 2020, he was Professor of Pharmacology and Experimental Therapeutics, Professor of Dermatology, Associate Chair of the Department of Pharmacology and Experimental Therapeutics, and Director of the Melanoma Center at Boston University School of Medicine. Since 2007, he has been a lecturer at Harvard University, an assistant professor at Loyola University Chicago, and an assistant professor at Tufts University, and was promoted to associate professor in 2010. He has long been involved in skin disease and tumor research, mainly in the development of new targeted drugs for melanoma, as well as exploring the biological mechanisms of pigment growth and melanoma development. To date, he has published 38 SCI papers, including Cell, Nature, Molecular Cell and Nature Communications. The cumulative IF scores are nearly 380. He is currently undertaking one key R&D project of MOST and one regional innovation (key) project of Foundation Committee. He has received seven NIH/NCIRO1 grants, two from the American Cancer Society, one from the U.S. Department of Defense, one from the Melanoma Research Foundation, one from the Harry Lloyd Research Foundation, and one from the Elisa U. Pardee Foundation as a project leader. He has received two U.S. patents and is a Life Fellow of the American Cancer Society.
